Huang and co‐workers evaluated the potential of berberine to improve cognitive dysfunction through enhancing autophagic clearance as well as inhibition of ß‐amyloid production in the APP/Tau/PS1 mouse model of Alzheimer's disease [51]. The gene discussed is MAPT; the disease is Alzheimer disease.